Patent Assignment
Reel/Frame 059265/0951
Assignment of Assignor's Interest
Recorded: 2022-03-15
Pages: 5
Assignor
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Executed: 2014-04-02
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
Treatment of Cancer Using Humanized Anti-CD19 Chimeric Antigen Receptor
Application:
17/132,674 →
Publication:
US 2021/0284752
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 15, 2022
From: BROGDON, JENNIFER; LOEW, ANDREAS
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 059265/0859 →
Assignment of Assignor's Interest
Mar 15, 2022
From: JUNE, CARL H.; MAUS, MARCELA; SCHOLLER, JOHN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 059365/0651 →
Assignment of Assignor's Interest
Dec 23, 2025
From: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
To: NOVARTIS AG; THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 073304/0289 →
Assignment of Assignor's Interest
Dec 23, 2025
From: NOVARTIS AG
To: NOVARTIS AG; THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 073304/0610 →